Novalon Games signs LOI to license new biofeedback technology for mobile gaming applications

NewsGuard 100/100 Score

Novalon Games, a wholly owned subsidiary of OBJ Enterprises (OTCBB: OBJE), announced today that it has signed a letter of intent (LOI) to partner with a cutting-edge game developer and potentially license innovative biofeedback technology for use in its growing suite of mobile gaming applications.

Flying Mollusk, LLC, is a Los Angeles-based game development company that has become a leader in the implementation of advanced biofeedback tools to enhance video gaming experiences. The company has developed a breakthrough biofeedback technology that connects players to gaming devices via heart-monitoring sensors, which can then adapt gameplay to suit or challenge gamers' stress levels. It's a major innovation with the potential to shatter traditional limits on games' interactivity.

According to the terms of the LOI, OBJE will have an option period of 90 days to conduct due diligence toward licensing and revenue-sharing opportunities with Flying Mollusk, with the possibility of entering into potentially lucrative joint venture, development and partnership agreements.

"Flying Mollusk is integrating cutting-edge technologies into games in a way that's never been seen before," said OBJE CEO Paul Watson. "We are extremely excited to discuss ways that we might leverage their top-notch development team to help create a new slate of applications for the mobile market under the Novalon Games brand."

The company is working to build a robust portfolio of engaging new content to capitalize on the explosion in gaming across the globe. Through its gaming division, Obscene Interactive, OBJE is working to deliver new and innovative gaming products for the Apple App Store and Google Play market alongside companies such as Glu Mobile Inc. (NASDAQ: GLUU) and The9 Limited (NASDAQ: NCTY).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals lifestyle factors boosting IVF success